These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Partial and re-partial splenectomies in Gaucher disease. The rational surgical approach]. Zer M; Freud E Harefuah; 1991 Dec; 121(11):471-4. PubMed ID: 1786900 [No Abstract] [Full Text] [Related]
46. Medical complications of renal transplantation. Orlowski T; Gradowska L Pol Med J; 1971; 10(2):363-70. PubMed ID: 4934230 [No Abstract] [Full Text] [Related]
48. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs. Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174 [TBL] [Abstract][Full Text] [Related]
49. Gaucher's disease: a model for modern management of a genetic disease. Mistry PK J Hepatol; 1999; 30 Suppl 1():1-5. PubMed ID: 10370894 [No Abstract] [Full Text] [Related]
50. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]. Tóth J; Szücs FZ; Benkö K; Maródi L Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625 [TBL] [Abstract][Full Text] [Related]
51. Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease. Rose JS; Grabowski GA; Barnett SH; Desnick RJ AJR Am J Roentgenol; 1982 Dec; 139(6):1202-4. PubMed ID: 6983268 [No Abstract] [Full Text] [Related]
52. Chemical models and chemotherapy in the sphingolipidoses. Radin NS Adv Exp Med Biol; 1976; 68():453-72. PubMed ID: 820172 [No Abstract] [Full Text] [Related]
53. [A case report of eight-year follow-up after splenectomy for Gaucher disease]. Li X; Li M; Gao PJ Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):651-652. PubMed ID: 31594086 [TBL] [Abstract][Full Text] [Related]
54. Letter: Splenectomy and immunosuppression. Jacob ET; Shapira Z; Kaplun A; Better OS Nephron; 1974; 12(3):232. PubMed ID: 4600973 [No Abstract] [Full Text] [Related]
56. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease. Whittington R; Goa KL Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294 [TBL] [Abstract][Full Text] [Related]
57. Alglucerase. A review of its therapeutic use in Gaucher's disease. Whittington R; Goa KL Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912 [TBL] [Abstract][Full Text] [Related]
58. Biochemistry and genetics of gangliosidoses. Sandhoff K; Christomanou H Hum Genet; 1979; 50(2):107-43. PubMed ID: 116955 [TBL] [Abstract][Full Text] [Related]